logo
  

CDC Panel Backs Full Approval Of Pfizer-BioNTech COVID-19 Vaccine

U.S. Centers for Disease Control and Prevention advisory panel voted to recommend the use of the Pfizer and BioNTech COVID-19 vaccine for U.S. people 16 and older.

The recommendation came a week after the U.S. Food and Drug Administration granted full approval for the vaccine in the age group.

However, the vaccine's use in adolescents 12-15 will continue to have emergency authorization until more data accumulates.

last week, Pfizer said it sought an approval from the U.S. Food and Drug Administration for its booster dose of COVID-19 vaccine.

The Pfizer/BioNTech vaccine, marketed as Comirnaty, had been authorized for emergency use in the US since last December for people age 16 and older. In May, the authorization was extended to those 12 and older.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Networking systems firm Ciena Corp. reported on Thursday that profit for the fourth quarter increased from last year, driven by strong revenue growth despite supply chain challenges. Adjusted earnings per share met analysts' expectations and quarterly revenues topped them by a whisker. Louisville, Kentucky -based GE Appliances, owned by Chinese home appliances company Haier, is recalling to repair free-standing and slide-in electric and gas ranges due to tip-over risk, the U.S. Consumer Product Safety Commission announced. The recall involves about 132,000 units of electric and gas ranges sold in the United States. In addition, about 12,960 units were sold in Canada. While reporting financial results for the first quarter on Wednesday, United Natural Foods, Inc. (UNFI) affirmed its earnings, adjusted earnings and sales guidance for the full-year 2021. For fiscal 2022, the company continues to project earnings in the range of $3.60 to $3.90 per share and adjusted...
Follow RTT